Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol vs quetiapine for prevention of delirium in end-stage cancer palliative home care
IRCT20201205049612N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in delirium and cancer comparing Haloperidol prophylaxis with Quetiapine prophylaxis (2 arms). Primary endpoint: Incidence of delirium. Started Dec 2020; status: completed.
02
Drugs
haloperidolquetiapine
03
Conditions
deliriumcancer
Beyond the preview
Go deeper on IRCT20201205049612N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201205049612N1.